Beijing, China · Founded 2010 · In IPO Registration
Developer and manufacturer of first-in-class natural drug innovations and advanced drug delivery systems designed for the treatment of complex metabolic disorders, malignant tumors, and… WeHand-Bio is based in Beijing, China and was founded in 2010. Its last reported valuation was $567 million in Sep 2025. It has raised $162 million.
Last reported valuation
$566.6M
Oct 2026
Priced at
—
Total raised
$162.0M
Last round
—
Cap table — not yet on record
WeHand-Bio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of WeHand-Bio with a free account
·Watch WeHand-Bio: the Monday email on marks, rounds and moves
